Web12 hours ago · Cytokinetics (CYTK) In a report released yesterday, Madhu Kumar from Goldman Sachs maintained a Buy rating on Cytokinetics. The company’s shares closed … WebDec 13, 2024 · SOUTH SAN FRANCISCO, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced that Nasdaq has halted the trading of the Company’s common stock.
Cytokinetics (@Cytokinetics) / Twitter
WebFeb 15, 2024 · Cytokinetics, Incorporated SOUTH SAN FRANCISCO, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report fourth quarter... WebFeb 28, 2024 · In 2024, Cytokinetics is celebrating its 25-year history of pioneering innovation in muscle biology and related pharmacology focused to diseases of muscle … hemoglobin abnormality
For Cytokinetics, FDA rejection of heart drug would help, not hinder
WebFeb 27, 2024 · For Cytokinetics, an FDA rejection of its heart drug would help, not hinder. By Adam Feuerstein. Reprints. Molly Ferguson/STAT. C ytokinetics was founded 26 … WebCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2024 it granted stock options to purchase an aggregate of 57,600 shares of common stock to 4 new … WebApr 13, 2024 · China Universal Asset Management Co. Ltd. trimmed its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 96.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.The institutional investor owned 961 shares of the biopharmaceutical … hemoglobin above normal in dogs